Phase II Study of Trametinib Alone and in Combination with Uprosertib in Patients with Metastatic Triple Negative Breast Cancer Previously Treated with Chemotherapy: OSU 13317
Cancer Research(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined